NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Miraqules

Miraqules

Private
BangaloreHealthcare & Life Scienceshttps://www.miraqules.com/

Last Round

Accelerator

Jul 10, 2023

Est. Valuation

$1.8M

Total Funding Raised

$1.05M

Company Overview

Miraqules is a healthcare and life sciences company that develops and manufactures nano-biopolymer hemostatic solutions for rapid hemorrhage control.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Advanced Materials, Defense Tech

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

hemostatic agenthemorrhage controltrauma managementbiomaterialmedical devicestop the bleedtactical medicinecombat gauzepoint-of-carenano-biopolymerwound careemergency medical suppliessurgical hemostatdefense techmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Miraqules Comparables

Compare Miraqules with similar companies based on industry and business-model similarity.

Miraqules comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CELOX Medical
83%
Axio Biosolutions
79%
Cresilon
78%

Miraqules Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorJul 10, 2023
Early FundingMar 31, 2022
GrantOct 21, 2021
GrantSep 1, 2020
GrantJan 1, 2020
Grant
Oct 1, 2019

Key People

Founding team and executive leadership

Mubeen Midda

Co-founder And Chief Medical Officer

Founding Team

Sabir Hossain

Founder CEO

Founding Team

Miraqules Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 27, 2025

    Will showcase blood clotting technology at TechCrunch Disrupt 2025.

Miraqules Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Miraqules Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Miraqules's valuation, stock price, and market status.

Firmographic Details

HeadquartersBangalore
Employee Range4
Year Founded2018
Last FundingJul 10, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.